Company CVAbout Unichem Laboratories Ltd 
Unichem Laboratories Ltd
Small Cap
Pharmaceuticals & Biotechnology
Unichem Laboratories Limited is an India-based pharmaceutical company, which manufactures active pharmaceutical ingredients. The company operates through four divisions, namely Unichem Pharma Division, Unichem Specialities Division, Unisearch Division and Neu-Foreva Division. The company is headquartered in Mumbai with five manufacturing facilities located at Roha in Maharashtra, Goa, Ghaziabad in Uttar Pradesh, Pithampur in Madhya Pradesh and Baddi in Himachal Pradesh.
Company Coordinates
Company Details
Unichem Bhavan Prabhat Estate, Off S V Road Jogeshwari (West) Mumbai Maharashtra : 400102
Registrar Details
Link Intime India Pvt Ltd, C-13 Pannalal Silk Compound, L B S Marg, Bhandup , Mumbai
Capital StructureCapital Structure
Present Equity Capital
INR 14.08 Cr
Number of Shares
7.04 Cr
Face Value
INR 2.0
Date
Number
of Shares(Cr)
of Shares(Cr)
Equity
Capital (Rs Cr)
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
14-Nov-2018
7.04
14.08
40175
2
ESOP
08-Jan-2018
9.09
18.19
1000
2
ESOP
28-Nov-2017
9.09
18.19
16800
2
ESOP
30-May-2017
9.09
18.18
17125
2
ESOP
11-Apr-2017
9.09
18.18
2025
2
ESOP
11-Apr-2017
9.09
18.18
2025
2
ESOP
01-Apr-2017
9.09
18.18
25550
2
ESOP
01-Apr-2017
9.09
18.18
25550
2
ESOP
21-Jan-2017
9.09
18.18
2025
2
ESOP
21-Jan-2017
9.09
18.18
2025
2
ESOP
ShareholdingShareholding Snapshot
Shareholding Compare (%holding)
Majority shareholders
Promoters
Pledged Promoter Holdings
None
Mutual Funds
Held by 5 Schemes (9.17%)
FIIs
Held by 37 FIIs (1.0%)
Promoter with highest holding
Ipca Laboratories Limited (52.67%)
Highest Public shareholder
Hdfc Small Cap Fund (7.75%)
Individual Investors Holdings
15.26%
Board of Directors
Management
Designation
Remuneration
Prafull Anubhai
Independent Non Exe. Director
13.5 lacs
Anand Mahajan
Independent Non Exe. Director
12.0 lacs
Prafull D Sheth
Independent Non Exe. Director
13.5 lacs
Priti Puri
Independent Non Exe. Director
0
Pranay Godha
Non-Exec & Non-Independent Dir
0
Pabitra Bhattacharya
Managing Director
0
Raw MaterialsRaw Materials Dashboard
Raw Materials
Amount(Rs Cr)
% of RM Cost
No Data Available for Raw Material Segmentation
No Data Available
Finished Goods Finished Goods Dashboard
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Formulations
783.92
80.33%
Bulk Drugs and Chemicals
126.49
12.96%
Export Benefits
40.73
4.17%
Formulations
Formulations
Bulk Drugs and Chemicals
Bulk Drugs and Chemicals
Export Benefits
Export Benefits
Stock DNARevenue and Profits:
Net Sales:
579 Cr
(Quarterly Results - Sep 2025)
Net Profit:
-12 Cr
Pharmaceuticals & Biotechnology
INR 3,151 Cr (Small Cap)
22.00
34
0.00%
0.13
6.03%
1.31
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
